Evaluation of a Bayesian method using a 1-point level for predicting individual vancomycin serum concentrations

Japanese Journal of Chemotherapy

Volumn 50, Issue 11, 2002, Pages 826-829

  Igarashi, Masahiro ^a   Nakatani, Tatsuo ^a   Hayashi, Masahiro ^a   Nakata, Koichiro ^a   Kasuya, Yasuji ^b  

^a TORANOMON HOSPITAL   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Bayesian method; Pharmacokinetics; TDM; Vancomycin

Indexed keywords

VANCOMYCIN;

ACCURACY; ARTICLE; BAYES THEOREM; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MONITORING; HUMAN; PROSPECTIVE STUDY; STEADY STATE; VALIDATION PROCESS;

EID: 0036859448     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Japanese source Therapeutic Drug Monitoring (TDM) vancomycin 48: 545-552, 2000
2. Japanese source Cockcroft Moellering vancomycin 49: 170-178, 2001
3. Saunders N J: Why monitor peak vancomycin concentrations?. Lancet 345: 646-647, 1995
4. Peck C C, Argenio D Z D, Rodman J H: Analysis of pharmacokinetic data for individualizaing drug dosage regimens. In Applied Pharmacokinetics. 3rd ed, (Evans W E, Schentag J J, Jusko W J, ed.) p.3-1-3-31, Applied Therapeutics, Vancouver, WA, 1992
5. Pryka R D, Rodvold K A, Garrison M, et al.: Individualizaing vancomycin dosage regimens: one-versus two-compartment Bayesian models. Ther Drug Monit 11: 450-454, 1989
6. Sheiner L B, Beal S L: Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 9: 503-512, 1981
7. Japanese source Bayesian vancomycin 50: 363-370, 2002